Pfizer Inc. (PFE.DE)
XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
As of 12:49PM CEST. Market open.
| Previous close | 26.30 |
| Open | 26.53 |
| Bid | 26.35 x 0 |
| Ask | 26.38 x 0 |
| Day's range | 26.31 - 26.58 |
| 52-week range | 23.53 - 37.50 |
| Volume | |
| Avg. volume | 63,188 |
| Market cap | 150.597B |
| Beta (5Y monthly) | 0.58 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.56 (5.93%) |
| Ex-dividend date | 09 May 2024 |
| 1y target est | N/A |
- Insider Monkey
The Most Profitable Biotechnology Company in the World
In this article, we will be taking a look at the most profitable biotechnology company in the world. If you want to learn about more, head straight to the 15 Most Profitable Biotechnology Companies in the World. Global Biotechnology Market Forecast: Strong Growth Driven by Healthcare and Food & Agriculture Innovations The global biotechnology market was valued […]
- Investor's Business Daily
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
The FDA approved Moderna's RSV vaccine, allowing the biotech to launch its second-ever product. But Moderna stock retreated.
- Zacks
Pfizer (PFE) Up 1.8% Since Last Earnings Report: Can It Continue?
Pfizer (PFE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
© 2024 Yahoo. All rights reserved.